| abstract |
REFERRED TO A COMPOUND OF FORMULA I, WHERE R1 IS ALCOXY, (ALCOXICARBONYLAMINO) ALCOXI, PHENYL SUBSTITUTED OR NOT, HALOALKYL, AMONG OTHERS; R2 IS H, HALO, NITRO, AMONG OTHERS; R3 IS CYANE, ALCOXYCARBONYL, TRIAZOLYL, AMONG OTHERS; R4 IS PHENYL, SUBSTITUTED OR NOT WITH 0-2 HALO; R20 IS H, HALO, ALKYL, ALCOXY; R21 H, HALO, ALKYL, ALCOXI. PREFERRED COMPOUNDS ARE: 2- (4-FLUOROPHENYL) -N-METHYL-5- (2-METHYL-5- (1- (PYRIMIDIN-2-IL) CYCLOPROPYLCARBAMOIL) PHENYL) BENZOFURAN-3-CARBOXAMIDE; 5- (3-FLUORO-METHYL-5- (1- (PYRIDIN-2-IL) CYCLOPROPYLCARBAMOYL) PHENYL) -2- (4-FLUOROPHENYL) -N-METHYLBENZOFURAN-3-CARBOXAMIDE; AMONG OTHERS. ALSO REFERRED TO A PHARMACEUTICAL COMPOSITION AND A PREPARATION PROCEDURE. SUCH COMPOUNDS HAVE ACTIVITY ON HEPATITIS C VIRUSES |